Chronic Kidney Disease Publications
About CDC’s CKD Initiative
Narva AS, Briggs M, Jordan R, Pavkov ME, Burrows NR, Williams DE. Toward a more collaborative federal response to chronic kidney disease. [PDF-406KB] Adv Chronic Kidney Dis. 2010;17(3):282−288.
Albright A, Burrows NR, Jordan R, Williams DE. The Kidney Disease Initiative and the Division of Diabetes Translation at the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53(3 Suppl 3):S121–S125.
Principles and Data Sources for CKD Surveillance
Radhakrishnan J, Remuzzi G, Saran R, et al. Taming the chronic kidney disease epidemic: a global view of surveillance efforts. [PDF-282KB] Kidney Int. 2014;86(2):246-250.
Grams ME, Plantinga LC, Hedgeman E, et al. Validation of CKD and related conditions in existing data sets: a systematic review. [PDF-363KB] Am J Kidney Dis. 2011;57(1):44–54.
Grams ME, Plantinga LC, Hedgeman E, et al. Establishing a national chronic kidney disease surveillance system for the United States. [PDF-110KB] Clin J Am Soc Nephrol. 2010;5(1):152−161.
Powe NR, Plantinga L, Saran R. Public health surveillance of CKD: principles, steps, and challenges. [PDF-357KB] Am J Kidney Dis. 2009;53(3 Suppl 3):S37−S45.
Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Rabon-Stith K, McClellan W. Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention. Am J Kidney Dis. 2009;53(3):522−535.
Schoolwerth AC, Engelgau MM, Hostetter TH, et al. Chronic kidney disease: a public health problem that needs a public health action plan. [PDF-190KB] Prev Chronic Dis. 2006;3(2):A57.
Natural History of CKD
Huang Y, Tilea A, Gillespie B, et al. Understanding trends in kidney function 1 year after kidney transplant in the United States. J Am Soc Nephrol. 2017 Mar 7. [Epub ahead of print].
Wong SP, Hebert PL, Laundry RJ, et al. Decisions about renal replacement therapy in patients with advanced kidney disease in the US Department of Veterans Affairs, 2000–2011. Clin J Am Soc Nephrol. 2016 Sep 22. [Epub ahead of print]
Hsu RK, McCulloch CE, Heung M, et al. Exploring potential reasons for the temporal trend in dialysis-requiring AKI in the United States. Clin J Am Soc Nephrol. 2016;11(1):14-20.
Wong SP, Vig EK, Taylor JS, et al. Timing of initiation of maintenance dialysis: a qualitative analysis of the electronic medical records of a national cohort of patients from the Department of Veterans Affairs. JAMA Intern Med. 2016 ;176(2):228-235.
O’Hare AM, Batten A, Burrows NR, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis. 2012 Apr;59(4):513–522.
O’Hare AM, Hailpern SM, Pavkov ME, et al. Prognostic implications of the urinary albumin to creatinine ratio in veterans of different ages with diabetes. Arch Intern Med. 2010;170(11):930−936.
Screening for CKD
Saydah SH, Pavkov ME, Zhang C, et al. Albuminuria prevalence in first morning void compared with previous random urine from adults in the National Health and Nutrition Examination Survey, 2009–2010. Clin Chem. 2013;59(4):1–9.
Vassalotti JA, Fox CH, Becker BN. Risk factors and screening for chronic kidney disease. Adv Chronic Kidney Dis. 2010;17(3):237–245.
Collins AJ, Vassalotti JA, Wang C, et al. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis. 2009;53(3 Suppl 3):S71–77.
Awareness of CKD
Tuot DS, Plantinga LC, Hsu CY, et al. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. [PDF-201KB] Clin J Am Soc Nephrol. 2011;6(8):1838–1844.
Plantinga LC, Tuot DS, Powe NR. Awareness of chronic kidney disease among patients and providers. [PDF-226KB] Adv Chronic Kidney Dis. 2010;17(3):225–236.
Plantinga LC, Boulware LE, Coresh J, et al. Patient awareness of chronic kidney disease: trends and predictors. [PDF-986KB] Arch Intern Med. 2008;168(20):2268–2275.
Prevalence of CKD
Murphy D , McCulloch CE , Lin F , et al. Trends in prevalence of chronic kidney disease in the United States. Annual of Intern Med. 2016;165(7):473-481.
Hoerger TJ, Simpson SA, Yarnoff BO, et al. The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative. Am J Kidney Dis. 2015;65(3):403–411.
Shahinian VB, Hedgeman E, Gillespie BW, et al. Estimating prevalence of CKD stages 3–5 using health system data. Am J Kidney Dis. 2013;61(6):930–938.
Plantinga LC, Crews DC, Coresh J, et al. Prevalence of chronic kidney disease in U.S. adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010;5(4):673−682.
Crews DC, Plantinga LC, Miller ER III, et al. Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States. [PDF-468KB] Hypertension. 2010;55(5):1102−1109.
CKD Risk Factors and Complications
Heung M, Steffick DE, Zivin K, et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of Veterans Health Administration data. Am J Kidney Dis. 2016;67(5):742-752.
Banerjee T, Scherzer R, Powe NR, et al. Race and other risk factors for incident proteinuria in a national cohort of HIV-infected veterans. J Acquir Immune Defic Syndr. 2014;67(2):145-152.
Food and Diet
- Banerjee T, Crews DC, Wesson DE, et al; CDC CKD Surveillance Team. Food insecurity, CKD, and subsequent ESRD in US adults. Am J Kidney Dis. 2017 Feb 15. [Epub ahead of print]
Banerjee T, Crews DC, Wesson DE, et al. High dietary acid load predicts ESRD among adults with CKD. J Am Soc Nephrol. 2015;26(7):1693-1700.
Banerjee T, Crews DC, Wesson DE, et al. Dietary acid load and chronic kidney disease among adults in the United States. BMC Nephrol. 2014;15:137.
Crews DC, Kuczmarski MF, Grubbs V, et al. Effect of food insecurity on chronic kidney disease in lower-income Americans. Am J Nephrol. 2014;39(1):27–35.
Medicines and Supplements
Tuot DS, Lin F, Shlipak MG, et al. Potential impact of prescribing metformin according to eGFR rather than serum creatinine. Diabetes Care. 2015;38(11):2059-2067.
Grubbs V, Plantinga LC, Tuot DS, et al. Americans’ use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis. 2013;61(5):739–747.
Plantinga L, Grubbs V, Sarkar U, et al. Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. [PDF-332KB] Ann Fam Med. 2011;9(5):423–430.
Plantinga LC, Miller ER III, Stevens LA, et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999–2006. [PDF-484KB] Hypertension. 2009;54(1):47–56.
Carlos CA, McCulloch CE, Hsu CY, et al; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. Colon cancer screening among patients receiving dialysis in the United States: are we choosing wisely? J Am Soc Nephrol. 2017 Mar 23. [Epub ahead of print].
Gillespie BW, Morgenstern H, Hedgeman E, et al. Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA. Clin Kidney J. 2015;8(6):772‒780.
Plantinga L, Lee K, Inker LA, et.al. Association of sleep-related problems with CKD in the United States, 2005–2008. Am J Kidney Dis. 2011;58(4):554–564.
Grubbs V, Plantinga LC, Crews DC, et al. Vulnerable populations and the association between periodontal and chronic kidney disease. [PDF-212KB] Clin J Am Soc Nephrol. 2011;6(4):711–717.
Plantinga LC, Johansen K, Crews DC, et al. Association of CKD with disability in the United States. [PDF-596KB] Am J Kidney Dis. 2011;57(2):212–227.
Costs and Cost-effectiveness Studies
Yarnoff BO, Hoerger TJ, Simpson SK, et al; Centers for Disease Control and Prevention CKD Initiative. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease. BMC Nephrol. 2017;18(1):85.
Yarnoff BO, Hoerger TJ, Simpson SA, et al. The cost-effectiveness of anemia treatment for persons with chronic kidney disease.PLoS One. 2016;11(7):e0157323.
Honeycutt AA, Segel JE, Zhuo X, Hoerger TJ, Imai K, Williams D. Medical costs of CKD in the Medicare population.J Am Soc Nephrol. 2013;24(9):1478–1483.
Hoerger TJ, Wittenborn J, Zhuo X, et al. Cost-effectiveness of screening for microalbuminuria among African Americans. J Am Soc Nephrol. 2012;23(12):2035–2041.
Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 1. model construction, assumptions, and validation of health consequences. Am J Kidney Dis. 2010;55(3):452–462.
Hoerger TJ, Wittenborn JS, Segel JE, et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis. 2010;55(3):463–473.
Morbidity and Mortality Weekly Reports (MMWRs)
Incidence of ESRD
Bullock A, Burrows NR, Narva AS, et al.
Vital Signs: Decrease in Incidence of Diabetes-Related End-Stage Renal Disease among American Indians/Alaska Natives — United States, 1996–2013. January 13, 2017 / 66(01);26–32.
Burrows NR, Hora I, Williams DE, Geiss LS. Trends in Incidence of End-Stage Renal Disease Among Persons With Diagnosed Diabetes — Puerto Rico, 1996–2010. March 7, 2014 / 63(09);186-189.
Burrows NR, Hora I, Cho P, Gerzoff RB, Geiss LS. Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons With Diagnosed Diabetes—United States and Puerto Rico, 1996–2007. October 29, 2010 / 59(42);1361-1366.
Burrows NR, Wang J, Geiss LS, Venkat Narayan KM, Engelgau MM. Incidence of End-Stage Renal Disease Among Persons with Diabetes—United States, 1990–2002. November 4, 2005 / 54(43);1097-1100.
Gilbertson D, Burrows NR, Wang J, Rolka D, Geiss LS, Williams DE. Racial Differences in Trends of End-Stage Renal Disease, by Primary Diagnosis—United States, 1994–2004. March 23, 2007 / 56(11);253-256.
Prevalence of CKD and ESRD
Saydah S, Eberhardt M, Burrows NR, Williams D, Geiss L, Dorsey R. Prevalence of Chronic Kidney Disease and Associated Risk Factors United States, 1999–2004. March 2, 2007 / 56(08);161-165.
Pirtle CJ, Schoolwerth AC, Giles WH, Brown DW, Mokdad AH, Ford ES. State-Specific Trends in Chronic Kidney Failure—United States, 1990–2001. October 8, 2004 / 53(39);918-920.
Hospitalization and Mortality
Flowers NT, Croft JB. Hospitalization Discharge Diagnoses for Kidney Disease—United States, 1980–2005. March 28, 2008 / 57(12);309-312
Andrews A, El Reda DK, Radford G, Burrows NR, Ernst K. Kidney Disease Mortality—Michigan, 1989–2005. March 16, 2007 / 56(10);225-227.
Downham G, Jones E, Peterson P, et al. Reducing Bloodstream Infections in an Outpatient Hemodialysis Center — New Jersey, 2008–2011. March 16, 2012 / 61(10);169-173.
Srinivasan A, Wise M, Bell M, et al. Vital Signs: Central Line–Associated Blood Stream Infections—United States, 2001, 2008, and 2009. March 4, 2011 / 60(08);243-248.
Hallack R, Johnson G, Clement E, et al. Hepatitis C Virus Transmission at an Outpatient Hemodialysis Unit—New York, 2001–2008. March 6, 2009 / 58(08);189-194.
Ryan TP, McElwain LL, Murphy TD, Arduino MJ, Anderson SA. Elevated Serum Aluminum Levels in Hemodialysis Patients Associated with Use of Electric Pumps—Wyoming, 2007. June 27, 2008 / 57(25);689-691.
Turabelidze G, Elward A, Jones M, et al. Acute Allergic-Type Reactions Among Patients Undergoing Hemodialysis—Multiple States, 2007–2008. February 8, 2008 / 57(05);124-125.
Collins A, Forrest B, Klevens RM, et al. Invasive Methicillin-Resistant Staphylococcus aureus Infections Among Dialysis Patients—United States, 2005. March 9, 2007 / 56(09);197-199.
Cheng S, Abramova L, Saab G, et al. Nephrogenic Fibrosing Dermopathy Associated with Exposure to Gadolinium-Containing Contrast Agents—St. Louis, Missouri, 2002–2006. February 23, 2007 / 56(07);137-141.
- Page last reviewed: April 20, 2017
- Page last updated: April 20, 2017
- Content source:
- Maintained By:
- National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation